home / stock / fldm / fldm news

FLDM News and Press, Fluidigm Corporation From 11/07/23

Stock Information
Company Name: Fluidigm Corporation
Stock Symbol: FLDM
Market: NASDAQ
Website: fluidigm.com
Menu
FLDM FLDM Quote FLDM Short FLDM News FLDM Articles FLDM Message Board
Get FLDM Alerts

News, Short Squeeze, Breakout and More Instantly...
FLDM - Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results

Year-to-date revenue growth, gross margin expansion and operating expense reduction are testament to continued execution against financial objectives Planned merger with SomaLogic activates strategic M&A thesis SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bio...
FLDM - Standard BioTools to Present at the Jefferies London Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Executive Officer Michael Egholm, PhD, will give...

FLDM - Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023

SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that it will report third quarter 2023 financial results on Tuesday,...

FLDM - Why SomaLogic Stock Dived by 10% on Wednesday

2023-10-04 18:49:14 ET An upcoming merger involving SomaLogic (NASDAQ: SLGC) wasn't making investors happy on Wednesday. On its news that it would be combining with medical technology peer Standard BioTools (NASDAQ: FLDM) , investors traded out of the shares. Ultimately, Som...
FLDM - Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools

Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights Expands commercial reach ...

FLDM - Standard BioTools Reports Second Quarter 2023 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) (“Standard BioTools”, or the “Company”), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported f...

FLDM - Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results

SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that it will report second quarter 2023 financial results on Tuesday...
FLDM - Standard BioTools to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced Company management will participate in the following investor confe...

FLDM - Standard BioTools to Present at the Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Executive Officer Michael Egholm, PhD, will ...

FLDM - Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System

SOUTH SAN FRANCISCO, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced the launch of NGS library preparation functionality on the X9™ Hi...
Previous 10 Next 10